Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Roche,"Trastuzumab, subcutaneous","Breast cancer, same indication as IV trastuzumab","Trastuzumab, subcutaneous (Herceptin)",Only if cost neutral or cost saving,Community and Hospital,Oncology Agents and Immunosuppressants
